Brief: Erytech Announces Approval To Transfer Its Listing To The Nasdaq Capital Market
April 17 (Reuters) - Erytech Pharma SA ERYP.PA :
* ERYTECH ANNOUNCES APPROVAL TO TRANSFER ITS LISTING TO THE
NASDAQ
CAPITAL MARKET
Source text for Eikon: ID:nGNXb0nmgb
Further company coverage: ERYP.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure